Shape Memory Medical
San Jose, US · Delaware corporation · 2 known investors
Healthtechin /shape-memory-therapeutics-inc.
Founders & leadership
TR
Thom RascheDirector
TT
Thomas ThalerDirector
MH
Michael HensonExecutive Officer, Director
EF
Edward F. Ruppel, JrExecutive Officer, Director
CM
Carolyn M. BrugueraExecutive Officer
DM
Duncan MaitlandDirector
CK
Carla Kikken-JussenDirector
JH
Jonathan HartmanDirector
JY
James Y LancasterExecutive Officer, Director
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$6.9MraisedJul 2026 · 16 investors · Other Health CareRule 506(b)
▶$6.9MraisedJul 2026 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. Ruppel, JrExecutive Officer, Director
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Duncan MaitlandDirector
- Thom RascheDirector
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6.9M
- Minimum investment
- $25K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedMay 2026 · 44 investors · Other Health CareRule 506(b)
▶$17MraisedMay 2026 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thom RascheDirector
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Edward F. Ruppel, JrExecutive Officer, Director
- Carolyn M. BrugueraExecutive Officer
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $25K
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.5MraisedFeb 2024 · 73 investors · Other Health CareRule 506(b)
▶$30.5MraisedFeb 2024 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Thomas ThalerDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $37.8M
- Amount sold
- $30.5M
- Minimum investment
- $24.7K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedApr 2023 · 37 investors · Other Health CareRule 506(b)
▶$4.8MraisedApr 2023 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward F. RuppelExecutive Officer, Director
- Thomas ThalerDirector
- Duncan MaitlandDirector
- Michael HensonExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $4.8M
- Minimum investment
- $2.8K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.5MraisedJul 2022 · 37 investors · Other Health CareRule 506(b)
▶$11.5MraisedJul 2022 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas ThalerDirector
- Edward RuppelExecutive Officer, Director
- Duncan MaitlandDirector
- Michael HensonDirector
- Offering amount
- $19.5M
- Amount sold
- $11.5M
- Minimum investment
- $15.8K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedAug 2017 · 15 investors · Other Health CareRule 506(b)
▶$7MraisedAug 2017 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carolyn M. BrugueraExecutive Officer
- Thomas ThalerDirector
- Michael HensonDirector
- Jim GamettDirector
- Edward F. Ruppel, Jr.Executive Officer, Director
- Duncan MaitlandDirector
- Offering amount
- $14M
- Amount sold
- $7M
- Minimum investment
- $7.5K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3MraisedApr 2016 · 12 investors · Other Health CareRule 506(b)
▶$3MraisedApr 2016 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James Y. LancasterExecutive Officer
- Duncan MaitlandExecutive Officer, Director
- Edward F. RuppelExecutive Officer, Director
- Michael HensonDirector
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $28K
- First sale
- Apr 2016
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$616.5KraisedJan 2015 · 10 investors · Other Health CareRule 506(b)
▶$616.5KraisedJan 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Carla Kikken-JussenDirector
- Jonathan HartmanDirector
- Duncan MaitlandExecutive Officer, Director
- James Y LancasterExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $616.5K
- First sale
- Dec 2014
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.